

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 4.69365787 |
| 2 | central nervous system myelination (GO:0022010) | 4.63071245 |
| 3 | axon ensheathment in central nervous system (GO:0032291) | 4.63071245 |
| 4 | creatine metabolic process (GO:0006600) | 4.40231832 |
| 5 | negative regulation of protein localization to cell surface (GO:2000009) | 4.26213349 |
| 6 | cardiac myofibril assembly (GO:0055003) | 4.09484172 |
| 7 | muscle filament sliding (GO:0030049) | 3.95455776 |
| 8 | actin-myosin filament sliding (GO:0033275) | 3.95455776 |
| 9 | myofibril assembly (GO:0030239) | 3.91097912 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 3.90687608 |
| 11 | plasma membrane repair (GO:0001778) | 3.72664311 |
| 12 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.65407058 |
| 13 | heart trabecula formation (GO:0060347) | 3.63290245 |
| 14 | extracellular fibril organization (GO:0043206) | 3.61341688 |
| 15 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.57478015 |
| 16 | myelin maintenance (GO:0043217) | 3.55649401 |
| 17 | actin-mediated cell contraction (GO:0070252) | 3.49561465 |
| 18 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.42489251 |
| 19 | response to hepatocyte growth factor (GO:0035728) | 3.38683487 |
| 20 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.38683487 |
| 21 | actomyosin structure organization (GO:0031032) | 3.31053860 |
| 22 | ensheathment of neurons (GO:0007272) | 3.25789788 |
| 23 | axon ensheathment (GO:0008366) | 3.25789788 |
| 24 | fibril organization (GO:0097435) | 3.24124253 |
| 25 | myelination (GO:0042552) | 3.17065285 |
| 26 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.14222437 |
| 27 | fatty acid elongation (GO:0030497) | 3.11543093 |
| 28 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.11296154 |
| 29 | macroautophagy (GO:0016236) | 3.09826148 |
| 30 | regulation of actin filament-based movement (GO:1903115) | 3.09456835 |
| 31 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.08779693 |
| 32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.07264936 |
| 33 | cell migration involved in heart development (GO:0060973) | 3.06276671 |
| 34 | trabecula formation (GO:0060343) | 3.04554126 |
| 35 | protein hydroxylation (GO:0018126) | 3.04382401 |
| 36 | eye photoreceptor cell differentiation (GO:0001754) | 3.03674151 |
| 37 | photoreceptor cell differentiation (GO:0046530) | 3.03674151 |
| 38 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.00597279 |
| 39 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.00108835 |
| 40 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.98902023 |
| 41 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.91639928 |
| 42 | regulation of hypersensitivity (GO:0002883) | 2.90938141 |
| 43 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.90394557 |
| 44 | keratan sulfate catabolic process (GO:0042340) | 2.87015020 |
| 45 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.85571321 |
| 46 | skeletal muscle adaptation (GO:0043501) | 2.84152038 |
| 47 | response to methylmercury (GO:0051597) | 2.82532383 |
| 48 | striated muscle atrophy (GO:0014891) | 2.81419617 |
| 49 | adult heart development (GO:0007512) | 2.81403317 |
| 50 | cardiac muscle contraction (GO:0060048) | 2.80687942 |
| 51 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.80390529 |
| 52 | endocardial cushion development (GO:0003197) | 2.77952788 |
| 53 | positive regulation of macrophage differentiation (GO:0045651) | 2.75041847 |
| 54 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.73874030 |
| 55 | regulation of relaxation of muscle (GO:1901077) | 2.73695245 |
| 56 | adhesion of symbiont to host cell (GO:0044650) | 2.72006041 |
| 57 | virion attachment to host cell (GO:0019062) | 2.72006041 |
| 58 | cardiac muscle cell development (GO:0055013) | 2.71223748 |
| 59 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.71192142 |
| 60 | muscle tissue morphogenesis (GO:0060415) | 2.69614805 |
| 61 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.69326891 |
| 62 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.67924534 |
| 63 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.66975189 |
| 64 | negative regulation of platelet activation (GO:0010544) | 2.66645890 |
| 65 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.66435976 |
| 66 | endodermal cell differentiation (GO:0035987) | 2.65972478 |
| 67 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.64826938 |
| 68 | import into cell (GO:0098657) | 2.63701082 |
| 69 | regulation of membrane repolarization (GO:0060306) | 2.62733079 |
| 70 | myelination in peripheral nervous system (GO:0022011) | 2.62687282 |
| 71 | peripheral nervous system axon ensheathment (GO:0032292) | 2.62687282 |
| 72 | regulation of striated muscle contraction (GO:0006942) | 2.62450439 |
| 73 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.62345512 |
| 74 | actin filament-based movement (GO:0030048) | 2.61606278 |
| 75 | positive regulation of receptor recycling (GO:0001921) | 2.60908253 |
| 76 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.59491623 |
| 77 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.57789323 |
| 78 | natural killer cell mediated immunity (GO:0002228) | 2.57789323 |
| 79 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.56514403 |
| 80 | L-serine transport (GO:0015825) | 2.54229859 |
| 81 | extracellular matrix assembly (GO:0085029) | 2.52307548 |
| 82 | cardiac cell development (GO:0055006) | 2.51666467 |
| 83 | regulation of lipoprotein metabolic process (GO:0050746) | 2.51208709 |
| 84 | regulation of cell communication by electrical coupling (GO:0010649) | 2.50790002 |
| 85 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.50656884 |
| 86 | G-protein coupled receptor internalization (GO:0002031) | 2.48995290 |
| 87 | response to muscle activity (GO:0014850) | 2.48301243 |
| 88 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.48124571 |
| 89 | collagen fibril organization (GO:0030199) | 2.44476805 |
| 90 | tooth mineralization (GO:0034505) | 2.43547503 |
| 91 | regulation of metalloenzyme activity (GO:0048552) | 2.43079557 |
| 92 | response to redox state (GO:0051775) | 2.41067384 |
| 93 | phagocytosis, recognition (GO:0006910) | 2.40891780 |
| 94 | Golgi transport vesicle coating (GO:0048200) | 2.40365007 |
| 95 | COPI coating of Golgi vesicle (GO:0048205) | 2.40365007 |
| 96 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.39217280 |
| 97 | basement membrane organization (GO:0071711) | 2.38622919 |
| 98 | blood vessel maturation (GO:0001955) | 2.38556111 |
| 99 | peptidyl-proline hydroxylation (GO:0019511) | 2.37831147 |
| 100 | striated muscle contraction (GO:0006941) | 2.36359337 |
| 101 | protein heterotrimerization (GO:0070208) | 2.35688926 |
| 102 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.35530083 |
| 103 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.35403373 |
| 104 | regulation of sequestering of triglyceride (GO:0010889) | 2.35262372 |
| 105 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.31722619 |
| 106 | regulation of cardioblast differentiation (GO:0051890) | 2.31692897 |
| 107 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.31467124 |
| 108 | 4-hydroxyproline metabolic process (GO:0019471) | 2.30439069 |
| 109 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.30333804 |
| 110 | barbed-end actin filament capping (GO:0051016) | 2.29870856 |
| 111 | membrane tubulation (GO:0097320) | 2.29705037 |
| 112 | anterior/posterior axis specification, embryo (GO:0008595) | 2.29651025 |
| 113 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.28945372 |
| 114 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.27982359 |
| 115 | tricarboxylic acid cycle (GO:0006099) | 2.27409319 |
| 116 | skin morphogenesis (GO:0043589) | 2.27125040 |
| 117 | negative regulation of acute inflammatory response (GO:0002674) | 2.26330604 |
| 118 | carnitine shuttle (GO:0006853) | 2.26097295 |
| 119 | astrocyte differentiation (GO:0048708) | 2.26077379 |
| 120 | regulation of cardiac muscle contraction (GO:0055117) | 2.25371427 |
| 121 | protein targeting to plasma membrane (GO:0072661) | 2.25089576 |
| 122 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.23459204 |
| 123 | acyl-CoA biosynthetic process (GO:0071616) | 2.22753027 |
| 124 | thioester biosynthetic process (GO:0035384) | 2.22753027 |
| 125 | platelet degranulation (GO:0002576) | 2.22705318 |
| 126 | bone trabecula formation (GO:0060346) | 2.22131445 |
| 127 | adhesion of symbiont to host (GO:0044406) | 2.22115030 |
| 128 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.21741815 |
| 129 | skeletal muscle contraction (GO:0003009) | 2.21702661 |
| 130 | cellular response to interleukin-6 (GO:0071354) | 2.21055401 |
| 131 | decidualization (GO:0046697) | 2.19961845 |
| 132 | purine nucleotide transport (GO:0015865) | 2.19367519 |
| 133 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.18219281 |
| 134 | regulation of receptor recycling (GO:0001919) | 2.17655205 |
| 135 | muscle contraction (GO:0006936) | 2.16418936 |
| 136 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.16242890 |
| 137 | cardiac muscle hypertrophy (GO:0003300) | 2.16145926 |
| 138 | muscle atrophy (GO:0014889) | 2.15136907 |
| 139 | regulation of platelet aggregation (GO:0090330) | 2.13684883 |
| 140 | serine transport (GO:0032329) | 2.12961906 |
| 141 | fatty acid beta-oxidation (GO:0006635) | 2.12701796 |
| 142 | atrioventricular valve morphogenesis (GO:0003181) | 2.12588416 |
| 143 | protein localization to endosome (GO:0036010) | 2.11877223 |
| 144 | striated muscle hypertrophy (GO:0014897) | 2.11661394 |
| 145 | regulation of sarcomere organization (GO:0060297) | 2.11395475 |
| 146 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.11031796 |
| 147 | asymmetric protein localization (GO:0008105) | 2.10957576 |
| 148 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.10897190 |
| 149 | substrate-dependent cell migration (GO:0006929) | 2.10658819 |
| 150 | cellular response to epinephrine stimulus (GO:0071872) | 2.10507112 |
| 151 | astrocyte development (GO:0014002) | 2.10189564 |
| 152 | protein targeting to Golgi (GO:0000042) | 2.10027413 |
| 153 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.09574486 |
| 154 | aspartate family amino acid catabolic process (GO:0009068) | 2.09359221 |
| 155 | outflow tract septum morphogenesis (GO:0003148) | 2.08712765 |
| 156 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.08633368 |
| 157 | type B pancreatic cell proliferation (GO:0044342) | 2.08146689 |
| 158 | regulation of necroptotic process (GO:0060544) | 2.06844448 |
| 159 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.06010206 |
| 160 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.05287780 |
| 161 | protein maturation by protein folding (GO:0022417) | 2.03870653 |
| 162 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.02760235 |
| 163 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.01736162 |
| 164 | apoptotic cell clearance (GO:0043277) | 2.01699633 |
| 165 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.01634481 |
| 166 | negative regulation of viral entry into host cell (GO:0046597) | 2.01498627 |
| 167 | heart process (GO:0003015) | 2.01396711 |
| 168 | heart contraction (GO:0060047) | 2.01396711 |
| 169 | fibroblast migration (GO:0010761) | 2.01147469 |
| 170 | platelet dense granule organization (GO:0060155) | 2.01133653 |
| 171 | amino sugar catabolic process (GO:0046348) | 2.00897037 |
| 172 | response to magnesium ion (GO:0032026) | 2.00249753 |
| 173 | pericardium development (GO:0060039) | 1.99228345 |
| 174 | cell adhesion mediated by integrin (GO:0033627) | 1.97733376 |
| 175 | regulation of platelet activation (GO:0010543) | 1.96416706 |
| 176 | melanin biosynthetic process (GO:0042438) | 1.95563761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.67978273 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.84793948 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.51621828 |
| 4 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.33249876 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.23514798 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.22237972 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.21241304 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10496387 |
| 9 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.96212239 |
| 10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95681762 |
| 11 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.93723975 |
| 12 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.93723975 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87877475 |
| 14 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.86699787 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84732684 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83959431 |
| 17 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.80212302 |
| 18 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79685734 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76234514 |
| 20 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.75452156 |
| 21 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.75452156 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72098204 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70726384 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65732755 |
| 25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65732755 |
| 26 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.65228235 |
| 27 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63208122 |
| 28 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.60470381 |
| 29 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.60466307 |
| 30 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.59907473 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.59697055 |
| 32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.58028161 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.57239717 |
| 34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.49873534 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49586865 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.47362663 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45357563 |
| 38 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44983879 |
| 39 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43585335 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43317592 |
| 41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43071290 |
| 42 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.42226039 |
| 43 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.40267906 |
| 44 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39448523 |
| 45 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.36848651 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35128307 |
| 47 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.34453261 |
| 48 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34020783 |
| 49 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33375288 |
| 50 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32400094 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.32105045 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31835626 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31225783 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.27364104 |
| 55 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27221453 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27053373 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26477149 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.25572551 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24854804 |
| 60 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24292964 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23952040 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21916382 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20701513 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19771000 |
| 65 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.19364949 |
| 66 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18826126 |
| 67 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18563663 |
| 68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18547185 |
| 69 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18512598 |
| 70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17851404 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17683212 |
| 72 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17415780 |
| 73 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16723668 |
| 74 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15966290 |
| 75 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15886174 |
| 76 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15852240 |
| 77 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.15827893 |
| 78 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.15401954 |
| 79 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.15240268 |
| 80 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14778316 |
| 81 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14483962 |
| 82 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14321018 |
| 83 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13207222 |
| 84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12771259 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10949716 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10727490 |
| 87 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10309605 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08693169 |
| 89 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08519794 |
| 90 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.07345207 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07075904 |
| 92 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06852991 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06416777 |
| 94 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.06282778 |
| 95 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05735242 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05074908 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04955459 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04762166 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03961146 |
| 100 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03655730 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03628217 |
| 102 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03109406 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02804664 |
| 104 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02040374 |
| 105 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.01926156 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99027676 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99017751 |
| 108 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98879590 |
| 109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98803790 |
| 110 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98685824 |
| 111 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98364114 |
| 112 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97904326 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97725137 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97339513 |
| 115 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97167440 |
| 116 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96685950 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95592870 |
| 118 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95448757 |
| 119 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.95133722 |
| 120 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94313528 |
| 121 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93925161 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93788491 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93345092 |
| 124 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92288653 |
| 125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91906335 |
| 126 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91767840 |
| 127 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91435603 |
| 128 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90819088 |
| 129 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90660245 |
| 130 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.90450410 |
| 131 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89930345 |
| 132 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89930345 |
| 133 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.89696630 |
| 134 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.89475345 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88789004 |
| 136 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88692550 |
| 137 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88007828 |
| 138 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87710670 |
| 139 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87270619 |
| 140 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86963746 |
| 141 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86563296 |
| 142 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85886770 |
| 143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85682707 |
| 144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85666455 |
| 145 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84988753 |
| 146 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84979053 |
| 147 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.84342030 |
| 148 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84212863 |
| 149 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83643561 |
| 150 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83477592 |
| 151 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82603665 |
| 152 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81276781 |
| 153 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81248965 |
| 154 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81202359 |
| 155 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81014461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.59623487 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.57188789 |
| 3 | MP0000751_myopathy | 3.59805326 |
| 4 | MP0000749_muscle_degeneration | 3.18603276 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.08162012 |
| 6 | MP0003950_abnormal_plasma_membrane | 2.84538502 |
| 7 | MP0004036_abnormal_muscle_relaxation | 2.83436762 |
| 8 | MP0009840_abnormal_foam_cell | 2.56108663 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.52536586 |
| 10 | MP0005330_cardiomyopathy | 2.44377040 |
| 11 | MP0004215_abnormal_myocardial_fiber | 2.40608296 |
| 12 | MP0005275_abnormal_skin_tensile | 2.40290067 |
| 13 | MP0003646_muscle_fatigue | 2.37675723 |
| 14 | MP0000747_muscle_weakness | 2.30092938 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.22518818 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.09478162 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.01906474 |
| 18 | MP0001542_abnormal_bone_strength | 2.01520505 |
| 19 | MP0000750_abnormal_muscle_regeneration | 1.99069066 |
| 20 | MP0005083_abnormal_biliary_tract | 1.98982218 |
| 21 | MP0005464_abnormal_platelet_physiology | 1.95989898 |
| 22 | MP0002972_abnormal_cardiac_muscle | 1.95396246 |
| 23 | MP0006138_congestive_heart_failure | 1.94363056 |
| 24 | MP0004272_abnormal_basement_membrane | 1.92365226 |
| 25 | MP0005623_abnormal_meninges_morphology | 1.91922009 |
| 26 | MP0003279_aneurysm | 1.90995888 |
| 27 | MP0005620_abnormal_muscle_contractility | 1.88600149 |
| 28 | MP0000920_abnormal_myelination | 1.84578156 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.80103442 |
| 30 | MP0000759_abnormal_skeletal_muscle | 1.79159166 |
| 31 | MP0004043_abnormal_pH_regulation | 1.79082049 |
| 32 | MP0009384_cardiac_valve_regurgitation | 1.75234873 |
| 33 | MP0008775_abnormal_heart_ventricle | 1.74252300 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.73487965 |
| 35 | MP0002108_abnormal_muscle_morphology | 1.72740325 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.72509491 |
| 37 | MP0002269_muscular_atrophy | 1.70374329 |
| 38 | MP0005369_muscle_phenotype | 1.70000541 |
| 39 | MP0005408_hypopigmentation | 1.66609814 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.65734265 |
| 41 | MP0000003_abnormal_adipose_tissue | 1.63829550 |
| 42 | MP0000371_diluted_coat_color | 1.60489394 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.59775878 |
| 44 | MP0004130_abnormal_muscle_cell | 1.59061180 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.58115418 |
| 46 | MP0004233_abnormal_muscle_weight | 1.54076590 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.53664000 |
| 48 | MP0001958_emphysema | 1.51443140 |
| 49 | MP0010630_abnormal_cardiac_muscle | 1.50586809 |
| 50 | MP0005385_cardiovascular_system_phenoty | 1.48665905 |
| 51 | MP0001544_abnormal_cardiovascular_syste | 1.48665905 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.48021530 |
| 53 | MP0004510_myositis | 1.47086716 |
| 54 | MP0002877_abnormal_melanocyte_morpholog | 1.44847097 |
| 55 | MP0003724_increased_susceptibility_to | 1.44600419 |
| 56 | MP0005375_adipose_tissue_phenotype | 1.41965836 |
| 57 | MP0004484_altered_response_of | 1.37044699 |
| 58 | MP0001299_abnormal_eye_distance/ | 1.34408171 |
| 59 | MP0003136_yellow_coat_color | 1.33548751 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.33458545 |
| 61 | MP0003195_calcinosis | 1.33178082 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.30115320 |
| 63 | MP0003186_abnormal_redox_activity | 1.28679882 |
| 64 | MP0003011_delayed_dark_adaptation | 1.28486352 |
| 65 | MP0004085_abnormal_heartbeat | 1.27257734 |
| 66 | MP0002254_reproductive_system_inflammat | 1.25090803 |
| 67 | MP0000733_abnormal_muscle_development | 1.23709957 |
| 68 | MP0002295_abnormal_pulmonary_circulatio | 1.23408829 |
| 69 | MP0008260_abnormal_autophagy | 1.22166531 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.18084958 |
| 71 | MP0005164_abnormal_response_to | 1.17346422 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.16434615 |
| 73 | MP0005451_abnormal_body_composition | 1.16214420 |
| 74 | MP0002332_abnormal_exercise_endurance | 1.14273733 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 1.13472523 |
| 76 | MP0008004_abnormal_stomach_pH | 1.08400310 |
| 77 | MP0005023_abnormal_wound_healing | 1.07586356 |
| 78 | MP0001533_abnormal_skeleton_physiology | 1.06958340 |
| 79 | MP0009764_decreased_sensitivity_to | 1.05463510 |
| 80 | MP0005171_absent_coat_pigmentation | 1.05170410 |
| 81 | MP0000462_abnormal_digestive_system | 1.03918679 |
| 82 | MP0005670_abnormal_white_adipose | 1.03470057 |
| 83 | MP0003634_abnormal_glial_cell | 1.02491548 |
| 84 | MP0005508_abnormal_skeleton_morphology | 1.00836027 |
| 85 | MP0002896_abnormal_bone_mineralization | 1.00386160 |
| 86 | MP0003329_amyloid_beta_deposits | 1.00044585 |
| 87 | MP0009250_abnormal_appendicular_skeleto | 0.99956443 |
| 88 | MP0002933_joint_inflammation | 0.99354472 |
| 89 | MP0003283_abnormal_digestive_organ | 0.99072525 |
| 90 | MP0006082_CNS_inflammation | 0.92255151 |
| 91 | MP0006054_spinal_hemorrhage | 0.91186212 |
| 92 | MP0003828_pulmonary_edema | 0.90658421 |
| 93 | MP0003806_abnormal_nucleotide_metabolis | 0.88890317 |
| 94 | MP0003436_decreased_susceptibility_to | 0.88037229 |
| 95 | MP0010368_abnormal_lymphatic_system | 0.88018398 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.85951765 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.83901556 |
| 98 | MP0004134_abnormal_chest_morphology | 0.83670965 |
| 99 | MP0005390_skeleton_phenotype | 0.82064044 |
| 100 | MP0003091_abnormal_cell_migration | 0.81714144 |
| 101 | MP0002234_abnormal_pharynx_morphology | 0.81246914 |
| 102 | MP0002132_abnormal_respiratory_system | 0.80801849 |
| 103 | MP0003300_gastrointestinal_ulcer | 0.80784435 |
| 104 | MP0003690_abnormal_glial_cell | 0.79345667 |
| 105 | MP0000762_abnormal_tongue_morphology | 0.77854278 |
| 106 | MP0000230_abnormal_systemic_arterial | 0.77820033 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.77221075 |
| 108 | MP0000249_abnormal_blood_vessel | 0.76901778 |
| 109 | MP0000858_altered_metastatic_potential | 0.76813143 |
| 110 | MP0000579_abnormal_nail_morphology | 0.76733927 |
| 111 | MP0003045_fibrosis | 0.75892171 |
| 112 | MP0001243_abnormal_dermal_layer | 0.74426523 |
| 113 | MP0004885_abnormal_endolymph | 0.74206472 |
| 114 | MP0005165_increased_susceptibility_to | 0.73760662 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.73617616 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.73347821 |
| 117 | MP0002419_abnormal_innate_immunity | 0.73172221 |
| 118 | MP0001324_abnormal_eye_pigmentation | 0.71885039 |
| 119 | MP0005058_abnormal_lysosome_morphology | 0.71388808 |
| 120 | MP0002060_abnormal_skin_morphology | 0.71123429 |
| 121 | MP0003795_abnormal_bone_structure | 0.69866781 |
| 122 | MP0000604_amyloidosis | 0.69241641 |
| 123 | MP0006072_abnormal_retinal_apoptosis | 0.69058570 |
| 124 | MP0002127_abnormal_cardiovascular_syste | 0.68219692 |
| 125 | MP0000767_abnormal_smooth_muscle | 0.67885456 |
| 126 | MP0002128_abnormal_blood_circulation | 0.67619052 |
| 127 | MP0001661_extended_life_span | 0.67445521 |
| 128 | MP0000266_abnormal_heart_morphology | 0.66923062 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.65469871 |
| 130 | MP0000163_abnormal_cartilage_morphology | 0.64332687 |
| 131 | MP0004147_increased_porphyrin_level | 0.62381286 |
| 132 | MP0003385_abnormal_body_wall | 0.62150993 |
| 133 | MP0001879_abnormal_lymphatic_vessel | 0.61641220 |
| 134 | MP0005257_abnormal_intraocular_pressure | 0.60954233 |
| 135 | MP0002090_abnormal_vision | 0.59343605 |
| 136 | MP0010386_abnormal_urinary_bladder | 0.55213449 |
| 137 | MP0000428_abnormal_craniofacial_morphol | 0.54616281 |
| 138 | MP0002168_other_aberrant_phenotype | 0.54494118 |
| 139 | MP0000343_altered_response_to | 0.54287597 |
| 140 | MP0005388_respiratory_system_phenotype | 0.53995591 |
| 141 | MP0002133_abnormal_respiratory_system | 0.53995591 |
| 142 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53469899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber splitting (HP:0003555) | 5.04060283 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.59387655 |
| 3 | Hyporeflexia of lower limbs (HP:0002600) | 4.49661082 |
| 4 | Sudden death (HP:0001699) | 4.21929137 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.20770476 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 4.14036796 |
| 7 | Abnormality of the calf musculature (HP:0001430) | 3.84773987 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.83292038 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 3.78103182 |
| 10 | Ventricular tachycardia (HP:0004756) | 3.74028214 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.66069468 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.66069468 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.66069468 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 3.58926194 |
| 15 | Atrial fibrillation (HP:0005110) | 3.41184693 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 3.39708795 |
| 17 | Protrusio acetabuli (HP:0003179) | 3.39175183 |
| 18 | Ulnar deviation of the wrist (HP:0003049) | 3.35390887 |
| 19 | Aortic aneurysm (HP:0004942) | 3.34794759 |
| 20 | Broad metatarsal (HP:0001783) | 3.31348408 |
| 21 | Vascular tortuosity (HP:0004948) | 3.22024844 |
| 22 | Lipoatrophy (HP:0100578) | 3.21987986 |
| 23 | EMG: myopathic abnormalities (HP:0003458) | 3.20929702 |
| 24 | Cervical subluxation (HP:0003308) | 3.20726870 |
| 25 | Vertebral compression fractures (HP:0002953) | 3.19179819 |
| 26 | Difficulty running (HP:0009046) | 3.15857100 |
| 27 | Primary atrial arrhythmia (HP:0001692) | 3.06558218 |
| 28 | Increased variability in muscle fiber diameter (HP:0003557) | 3.01750673 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.97752252 |
| 30 | Increased connective tissue (HP:0009025) | 2.97205473 |
| 31 | Distal lower limb muscle weakness (HP:0009053) | 2.96042118 |
| 32 | Myoglobinuria (HP:0002913) | 2.93856742 |
| 33 | Peritonitis (HP:0002586) | 2.88476894 |
| 34 | Dilated cardiomyopathy (HP:0001644) | 2.86892663 |
| 35 | Supraventricular tachycardia (HP:0004755) | 2.85726907 |
| 36 | Slender build (HP:0001533) | 2.85710561 |
| 37 | Supraventricular arrhythmia (HP:0005115) | 2.84949890 |
| 38 | Prolonged QT interval (HP:0001657) | 2.84742461 |
| 39 | Arterial tortuosity (HP:0005116) | 2.82151035 |
| 40 | Menorrhagia (HP:0000132) | 2.77965702 |
| 41 | Ovoid vertebral bodies (HP:0003300) | 2.71629115 |
| 42 | Spinal rigidity (HP:0003306) | 2.70058794 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.68404617 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.68253201 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.66131979 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.66104065 |
| 47 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.63165845 |
| 48 | Scapular winging (HP:0003691) | 2.62890435 |
| 49 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.62608590 |
| 50 | Subaortic stenosis (HP:0001682) | 2.62608590 |
| 51 | Muscle fiber inclusion bodies (HP:0100299) | 2.60727853 |
| 52 | Syncope (HP:0001279) | 2.60412249 |
| 53 | Gowers sign (HP:0003391) | 2.60158830 |
| 54 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.56250390 |
| 55 | Increased serum ferritin (HP:0003281) | 2.52273938 |
| 56 | Purpura (HP:0000979) | 2.50513553 |
| 57 | Pheochromocytoma (HP:0002666) | 2.49436661 |
| 58 | Spondylolisthesis (HP:0003302) | 2.49111037 |
| 59 | Hypoplastic ischia (HP:0003175) | 2.49080249 |
| 60 | Large for gestational age (HP:0001520) | 2.46803531 |
| 61 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.46721333 |
| 62 | Myotonia (HP:0002486) | 2.45803322 |
| 63 | Fragile skin (HP:0001030) | 2.42640032 |
| 64 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.42558677 |
| 65 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.42558677 |
| 66 | Atrophic scars (HP:0001075) | 2.42333228 |
| 67 | Round ear (HP:0100830) | 2.40832652 |
| 68 | Bundle branch block (HP:0011710) | 2.40366693 |
| 69 | Neurofibrillary tangles (HP:0002185) | 2.40301063 |
| 70 | Increased mean platelet volume (HP:0011877) | 2.38622232 |
| 71 | Distal arthrogryposis (HP:0005684) | 2.38517729 |
| 72 | Shallow orbits (HP:0000586) | 2.38391761 |
| 73 | Gingival bleeding (HP:0000225) | 2.35392606 |
| 74 | Cerebral aneurysm (HP:0004944) | 2.35088579 |
| 75 | Petechiae (HP:0000967) | 2.32630749 |
| 76 | Mitral stenosis (HP:0001718) | 2.31588014 |
| 77 | Aortic dissection (HP:0002647) | 2.30384048 |
| 78 | Ketoacidosis (HP:0001993) | 2.27776526 |
| 79 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.27045379 |
| 80 | Myocardial infarction (HP:0001658) | 2.26958206 |
| 81 | Palpitations (HP:0001962) | 2.26875032 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.26829296 |
| 83 | Abnormal platelet volume (HP:0011876) | 2.24073212 |
| 84 | Bell-shaped thorax (HP:0001591) | 2.23750280 |
| 85 | Infantile muscular hypotonia (HP:0008947) | 2.22721437 |
| 86 | Onion bulb formation (HP:0003383) | 2.22492262 |
| 87 | Nemaline bodies (HP:0003798) | 2.21614248 |
| 88 | Soft skin (HP:0000977) | 2.21380757 |
| 89 | Abnormality of the ischium (HP:0003174) | 2.21131778 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 2.20788672 |
| 91 | Neck muscle weakness (HP:0000467) | 2.20388515 |
| 92 | Foot dorsiflexor weakness (HP:0009027) | 2.20145931 |
| 93 | Difficulty climbing stairs (HP:0003551) | 2.19136714 |
| 94 | Ventricular arrhythmia (HP:0004308) | 2.17799091 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16278531 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16278531 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16278531 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.10272788 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10272788 |
| 100 | Vacuolated lymphocytes (HP:0001922) | 2.08318980 |
| 101 | Abnormality of the foot musculature (HP:0001436) | 2.06810861 |
| 102 | Aneurysm (HP:0002617) | 2.06776509 |
| 103 | Hypoplasia of the iris (HP:0007676) | 2.06748906 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05698270 |
| 105 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.05490628 |
| 106 | Neuroendocrine neoplasm (HP:0100634) | 2.03580776 |
| 107 | Epistaxis (HP:0000421) | 2.02477704 |
| 108 | Abnormal atrioventricular conduction (HP:0005150) | 2.00949296 |
| 109 | Muscle stiffness (HP:0003552) | 2.00877215 |
| 110 | Ankle contracture (HP:0006466) | 1.98645203 |
| 111 | Heart block (HP:0012722) | 1.94896707 |
| 112 | Hyperlipoproteinemia (HP:0010980) | 1.93063302 |
| 113 | Diaphragmatic weakness (HP:0009113) | 1.92506812 |
| 114 | Joint stiffness (HP:0001387) | 1.91976277 |
| 115 | Abnormality of macrophages (HP:0004311) | 1.91006787 |
| 116 | Aplasia of the musculature (HP:0100854) | 1.90922402 |
| 117 | Dilatation of the ascending aorta (HP:0005111) | 1.89114163 |
| 118 | Hypoglycemic seizures (HP:0002173) | 1.87968224 |
| 119 | Abnormality of dentin (HP:0010299) | 1.86101949 |
| 120 | Bladder diverticulum (HP:0000015) | 1.85443300 |
| 121 | Myopathic facies (HP:0002058) | 1.82760762 |
| 122 | Wormian bones (HP:0002645) | 1.82294913 |
| 123 | Vascular calcification (HP:0004934) | 1.81763092 |
| 124 | Spontaneous hematomas (HP:0007420) | 1.81211010 |
| 125 | Muscular dystrophy (HP:0003560) | 1.81149652 |
| 126 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.79033273 |
| 127 | Hyperextensible skin (HP:0000974) | 1.78831798 |
| 128 | Distal upper limb amyotrophy (HP:0007149) | 1.77384488 |
| 129 | Upper limb amyotrophy (HP:0009129) | 1.77384488 |
| 130 | Cerebral inclusion bodies (HP:0100314) | 1.77142761 |
| 131 | Aortic regurgitation (HP:0001659) | 1.76771743 |
| 132 | Stridor (HP:0010307) | 1.76239313 |
| 133 | Abnormal gallbladder morphology (HP:0012437) | 1.76185749 |
| 134 | Hyperglycemia (HP:0003074) | 1.75740981 |
| 135 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.75467277 |
| 136 | Buphthalmos (HP:0000557) | 1.75364285 |
| 137 | Skin nodule (HP:0200036) | 1.74599901 |
| 138 | Abnormality of the neuromuscular junction (HP:0003398) | 1.74396471 |
| 139 | Fatigable weakness (HP:0003473) | 1.74396471 |
| 140 | Bruising susceptibility (HP:0000978) | 1.74234460 |
| 141 | Bradycardia (HP:0001662) | 1.72784365 |
| 142 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.72254444 |
| 143 | Hypoplasia of the fovea (HP:0007750) | 1.72254444 |
| 144 | Elbow flexion contracture (HP:0002987) | 1.71638333 |
| 145 | Hip contracture (HP:0003273) | 1.71336679 |
| 146 | Xanthomatosis (HP:0000991) | 1.71222780 |
| 147 | Rhabdomyolysis (HP:0003201) | 1.70914741 |
| 148 | Abnormal EKG (HP:0003115) | 1.70781801 |
| 149 | Congenital glaucoma (HP:0001087) | 1.70728979 |
| 150 | Atrioventricular block (HP:0001678) | 1.70638522 |
| 151 | Follicular hyperkeratosis (HP:0007502) | 1.70288795 |
| 152 | Ileus (HP:0002595) | 1.69028436 |
| 153 | Overgrowth (HP:0001548) | 1.68421432 |
| 154 | Hydroxyprolinuria (HP:0003080) | 1.67120740 |
| 155 | Abnormality of proline metabolism (HP:0010907) | 1.67120740 |
| 156 | Blue sclerae (HP:0000592) | 1.66498256 |
| 157 | Limb-girdle muscle atrophy (HP:0003797) | 1.65729361 |
| 158 | Aplasia involving bones of the extremities (HP:0009825) | 1.63454637 |
| 159 | Aplasia of the phalanges of the hand (HP:0009802) | 1.63454637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.67282601 |
| 2 | STK39 | 3.50241916 |
| 3 | TRIB3 | 3.29385456 |
| 4 | TIE1 | 3.02221016 |
| 5 | EPHB1 | 2.94693131 |
| 6 | MAPKAPK3 | 2.75890465 |
| 7 | WNK4 | 2.49101136 |
| 8 | LMTK2 | 2.46542616 |
| 9 | OBSCN | 2.37349411 |
| 10 | PHKG1 | 2.34792249 |
| 11 | PHKG2 | 2.34792249 |
| 12 | DMPK | 2.30821396 |
| 13 | MUSK | 2.08461835 |
| 14 | ADRBK2 | 2.03926081 |
| 15 | PIK3CA | 2.02247541 |
| 16 | TGFBR2 | 1.90034155 |
| 17 | PKN2 | 1.86149135 |
| 18 | MYLK | 1.83939347 |
| 19 | PAK3 | 1.80392869 |
| 20 | DDR2 | 1.78096513 |
| 21 | MET | 1.75612262 |
| 22 | MAP3K3 | 1.73355103 |
| 23 | ZAP70 | 1.69906347 |
| 24 | LATS1 | 1.67202043 |
| 25 | MAPKAPK5 | 1.63350049 |
| 26 | OXSR1 | 1.61072836 |
| 27 | PKN1 | 1.60041512 |
| 28 | INSRR | 1.56528368 |
| 29 | WNK1 | 1.56299712 |
| 30 | BCKDK | 1.50693205 |
| 31 | MAP2K3 | 1.48743285 |
| 32 | LIMK1 | 1.48182108 |
| 33 | TESK1 | 1.45797542 |
| 34 | CAMK1G | 1.44419737 |
| 35 | NTRK1 | 1.44059188 |
| 36 | GRK6 | 1.38660120 |
| 37 | TBK1 | 1.36503065 |
| 38 | PRKD1 | 1.33073271 |
| 39 | PDGFRA | 1.32681683 |
| 40 | CAMK2D | 1.30710798 |
| 41 | TRPM7 | 1.29796022 |
| 42 | SIK1 | 1.28869461 |
| 43 | PRKD3 | 1.28096115 |
| 44 | CAMK1D | 1.26057747 |
| 45 | ICK | 1.25549306 |
| 46 | GRK1 | 1.22326276 |
| 47 | SGK494 | 1.17725731 |
| 48 | SGK223 | 1.17725731 |
| 49 | BLK | 1.15347421 |
| 50 | PINK1 | 1.13396530 |
| 51 | ROCK2 | 1.13091608 |
| 52 | PDK4 | 1.12826921 |
| 53 | PDK3 | 1.12826921 |
| 54 | PDK2 | 1.11736060 |
| 55 | EPHA3 | 1.11264414 |
| 56 | NEK9 | 1.10098640 |
| 57 | BMX | 1.08533687 |
| 58 | IRAK3 | 0.99539240 |
| 59 | ABL2 | 0.98619442 |
| 60 | JAK1 | 0.97516335 |
| 61 | ADRBK1 | 0.97009763 |
| 62 | ILK | 0.96748651 |
| 63 | FER | 0.96217174 |
| 64 | PIM2 | 0.93956408 |
| 65 | FGFR2 | 0.93706829 |
| 66 | PRKCE | 0.93407788 |
| 67 | CDC42BPA | 0.92904274 |
| 68 | MAP3K11 | 0.91812568 |
| 69 | MAP3K12 | 0.91712054 |
| 70 | PIK3CG | 0.90641622 |
| 71 | MST4 | 0.90063645 |
| 72 | PTK2 | 0.87598099 |
| 73 | TYK2 | 0.85052538 |
| 74 | IRAK1 | 0.84778441 |
| 75 | ROCK1 | 0.84760092 |
| 76 | KDR | 0.84016240 |
| 77 | ERN1 | 0.83186732 |
| 78 | GRK5 | 0.80768327 |
| 79 | MAP3K5 | 0.80285455 |
| 80 | PTK6 | 0.77841635 |
| 81 | STK38 | 0.75058017 |
| 82 | CSK | 0.73343788 |
| 83 | MAPK15 | 0.71322698 |
| 84 | PTK2B | 0.69226107 |
| 85 | UHMK1 | 0.68606864 |
| 86 | IKBKB | 0.68559674 |
| 87 | PBK | 0.67390655 |
| 88 | TXK | 0.66418735 |
| 89 | IRAK4 | 0.65029917 |
| 90 | BMPR2 | 0.64771081 |
| 91 | PAK2 | 0.63988871 |
| 92 | KIT | 0.63280409 |
| 93 | MOS | 0.63102929 |
| 94 | MAP2K2 | 0.62477798 |
| 95 | CAMK2G | 0.62071839 |
| 96 | PDPK1 | 0.61172261 |
| 97 | MARK3 | 0.61101559 |
| 98 | MAP3K7 | 0.60429500 |
| 99 | PAK4 | 0.59703641 |
| 100 | TAOK2 | 0.59412461 |
| 101 | HIPK2 | 0.58727147 |
| 102 | CAMK2A | 0.58627548 |
| 103 | JAK3 | 0.57978448 |
| 104 | PDGFRB | 0.57192328 |
| 105 | FGFR4 | 0.56870236 |
| 106 | RET | 0.56617666 |
| 107 | PRKAA2 | 0.54761424 |
| 108 | EPHB2 | 0.54726078 |
| 109 | CAMK2B | 0.54684560 |
| 110 | BCR | 0.54233636 |
| 111 | PAK6 | 0.54047926 |
| 112 | MAPKAPK2 | 0.53698800 |
| 113 | IRAK2 | 0.52321772 |
| 114 | NEK6 | 0.51795329 |
| 115 | MAP3K1 | 0.51680255 |
| 116 | AKT3 | 0.51338509 |
| 117 | MARK2 | 0.51064808 |
| 118 | LATS2 | 0.49405275 |
| 119 | MAPK11 | 0.49068836 |
| 120 | PRKAA1 | 0.48365319 |
| 121 | RPS6KA2 | 0.48112620 |
| 122 | CHUK | 0.46536082 |
| 123 | JAK2 | 0.45862578 |
| 124 | MAP2K1 | 0.45571972 |
| 125 | LRRK2 | 0.44745861 |
| 126 | MTOR | 0.43849967 |
| 127 | KSR2 | 0.43282322 |
| 128 | PRKCH | 0.42230206 |
| 129 | RIPK1 | 0.41979413 |
| 130 | MAPK12 | 0.41349299 |
| 131 | DAPK3 | 0.40902542 |
| 132 | PRKD2 | 0.39791534 |
| 133 | GSK3A | 0.38122702 |
| 134 | TESK2 | 0.38083561 |
| 135 | DYRK1B | 0.37543237 |
| 136 | PRKACB | 0.37167711 |
| 137 | GRK7 | 0.36181321 |
| 138 | PRKG1 | 0.35893244 |
| 139 | FLT3 | 0.34842895 |
| 140 | NME1 | 0.32508134 |
| 141 | CSNK1A1L | 0.32188082 |
| 142 | SGK3 | 0.31972627 |
| 143 | STK38L | 0.31794028 |
| 144 | TAOK3 | 0.31106218 |
| 145 | PRKG2 | 0.30585572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.92853741 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.75858168 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.72627224 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.62174286 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.58395169 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.53086724 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.49632601 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.44739482 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.29216673 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.26186101 |
| 11 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.21702639 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.17563209 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14988539 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.14546334 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.98005748 |
| 16 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.97421704 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.96378719 |
| 18 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.95135203 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.87776042 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86109261 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79017606 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.78040585 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.76874944 |
| 24 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.74635455 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68377923 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.64943999 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.63725692 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.62221446 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.61551705 |
| 30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.59362499 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.58134909 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.53876021 |
| 33 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.49163898 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48197260 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45801604 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.45047998 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.41275092 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 1.27836307 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.21788493 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20075506 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19888394 |
| 42 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.19221326 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.19124967 |
| 44 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.15825311 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12259034 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06011977 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05958061 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05150570 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.03976247 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 1.02935419 |
| 51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02159782 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01628651 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01517712 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.00697688 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99621939 |
| 56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98344320 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95888699 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.95290390 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.89946669 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89167651 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88037873 |
| 62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.87157486 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 0.85898745 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84252810 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83262350 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83252973 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81765600 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81649282 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80998514 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80432155 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80349773 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79276679 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78128407 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77745314 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.77135102 |
| 76 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.75222725 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75079016 |
| 78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72882489 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71609116 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71533715 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70359296 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70214370 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.70132804 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70029626 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69858243 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.69684754 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69106245 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68451335 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67915129 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.67120902 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.66666943 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.66288697 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66146444 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65547807 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.64412917 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63161032 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.62486076 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.61892479 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61876976 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61568986 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61561421 |
| 102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61164358 |
| 103 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.60200782 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59895419 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59545279 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.59070732 |
| 107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.57998000 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57969278 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57794584 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57638225 |
| 111 | Axon guidance_Homo sapiens_hsa04360 | 0.57000299 |
| 112 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56054346 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55943034 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.55514221 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53109010 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52221592 |
| 117 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.52201649 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52189334 |
| 119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50382810 |
| 120 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50126955 |
| 121 | Apoptosis_Homo sapiens_hsa04210 | 0.49647788 |
| 122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47899928 |
| 123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45778114 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45652201 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44486172 |
| 126 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43133011 |
| 127 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42593907 |
| 128 | Phototransduction_Homo sapiens_hsa04744 | 0.41889624 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41827429 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41245874 |
| 131 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40861432 |
| 132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40420509 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40228692 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39323719 |
| 135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39274076 |
| 136 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39205013 |
| 137 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37980875 |
| 138 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37675495 |
| 139 | ABC transporters_Homo sapiens_hsa02010 | 0.37278141 |
| 140 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37118603 |
| 141 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37106842 |
| 142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36692704 |
| 143 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36303554 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.36193672 |
| 145 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35978764 |
| 146 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35087864 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34732559 |
| 148 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34232594 |
| 149 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.33958977 |
| 150 | Bile secretion_Homo sapiens_hsa04976 | 0.33948744 |
| 151 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32983429 |
| 152 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32001334 |
| 153 | Melanogenesis_Homo sapiens_hsa04916 | 0.31514224 |
| 154 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31355350 |
| 155 | Gap junction_Homo sapiens_hsa04540 | 0.31214100 |
| 156 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.31190061 |
| 157 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31111376 |

